Acute hepatitis C in Korea: Different modes of infection, high rate of spontaneous recovery, and low rate of seroconversion

Journal of Medical Virology

Volumn 83, Issue 7, 2011, Pages 1195-1202

  Kim, Jong Yeop ^a   Won, Ji Eon ^a   Jeong, Sook Hyang ^a   Park, Sang Jong ^b   Hwang, Seong Gyu ^c   Kang, Sook Kyoung ^d   Bae, Si Hyun ^e   Kim, Young Seok ^f   Lee, Han Chu ^g  

^a Seoul National University Bundang Hospital   (South Korea)

^b Bundang Jesaeng Hospital   (South Korea)

^c CHA University   (South Korea)

^d Seongnam Central Hospital   (South Korea)

^e The Catholic University of Korea   (South Korea)

^f Soonchunhyang University   (South Korea)

^g University of Ulsan College of Medicine   (South Korea)

Author keywords

Acute hepatitis; Epidemiology; Hepatitis C virus; Korea; Seroconversion

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA2B INTERFERON; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS C ANTIBODY; PEGINTERFERON ALPHA2A; PROTHROMBIN; RIBAVIRIN;

ACUPUNCTURE; ACUTE HEPATITIS; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANGIOCARDIOGRAPHY; ANTIBODY TITER; ANTIVIRAL THERAPY; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER SURGERY; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONVALESCENCE; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; ESTHETIC SURGERY; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENOTYPE; GYNECOLOGIC SURGERY; HEPATITIS C; HUMAN; HUMAN CELL; INTRAARTICULAR DRUG ADMINISTRATION; INVASIVE PROCEDURE; KOREA; MALE; MULTICENTER STUDY; NEEDLESTICK INJURY; OUTCOME ASSESSMENT; PHOTOTHERAPY; PROTHROMBIN TIME; SEROCONVERSION; SEXUAL TRANSMISSION; SURGERY; TREATMENT RESPONSE;

ACUPUNCTURE; ACUTE DISEASE; ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEEDLESTICK INJURIES; REMISSION, SPONTANEOUS; REPUBLIC OF KOREA; RISK FACTORS; RNA, VIRAL; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 79955923620     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22100     Document Type: Article

References (45)

1. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. 1999. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341:556-562.
2. Barrett S, Sweeney M, Crowe J. 2005. Host immune responses in hepatitis C virus clearance. Eur J Gastroenterol Hepatol 17:1089-1097.
3. Blackard JT, Shata MT, Shire NJ, Sherman KE. 2008. Acute hepatitis C virus infection: A chronic problem. Hepatology 47:321-331.
4. Bonacini M, Govindarajan S, Blatt LM, Schmid P, Conrad A, Lindsay KL. 1999. Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA. J Viral Hepat 6:203-208.
5. Briat A, Dulioust E, Galimand J, Fontaine H, Chaix ML, Letur-Konirsch H, Pol S, Jouannet P, Rouzioux C, Leruez-Ville M. 2005. Hepatitis C virus in the semen of men coinfected with HIV-1: Prevalence and origin. AIDS 19:1827-1835.
6. Cho YP, Jang HJ, Kim JS, Kim YH, Han MS, Lee SG. 2003. Retroperitoneal abscess complicated by acupuncture: Case report. J Korean Med Sci 18:756-757.
7. Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, Chien DY, Houghton M, Parham P, Walker CM. 1999. Analysis of a successful immune response against hepatitis C virus. Immunity 10:439-449.
8. Cox AL, Netski DM, Mosbruger T, Sherman SG, Strathdee S, Ompad D, Vlahov D, Chien D, Shyamala V, Ray SC, Thomas DL. 2005. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis 40:951-958.
9. Donahue JG, Munoz A, Ness PM, Brown DE, Jr., Yawn DH, McAllister HA, Jr., Reitz BA, Nelson KE. 1992. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 327:369-373.
10. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB. 2009. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399-401.
11. Hofer H, Watkins-Riedel T, Janata O, Penner E, Holzmann H, Steindl-Munda P, Gangl A, Ferenci P. 2003. Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load. Hepatology 37:60-64.
12. Hwang SJ, Lee SD, Lu RH, Chu CW, Wu JC, Lai ST, Chang FY. 2001. Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C. J Med Virol 65:505-509.
13. Kamal SM, Moustafa KN, Chen J, Fehr J, Abdel Moneim A, Khalifa KE, El Gohary LA, Ramy AH, Madwar MA, Rasenack J, Afdhal NH. 2006. Duration of peginterferon therapy in acute hepatitis C: A randomized trial. Hepatology 43:923-931.
14. Kim KA, Lee JS, Yang JH, Moon YS, Lee WJ. 2005. Natural history of acute symptomatic hepatitis C in Korea. Korean J Gastroenterol 46:105-109.
15. Koh SJ, Song T, Kang YA, Choi JW, Chang KJ, Chu CS, Jeong JG, Lee JY, Song MK, Sung HY, Kang YH, Yim JJ. 2010. An outbreak of skin and soft tissue infection caused by Mycobacterium abscessus following acupuncture. Clin Microbiol Infect 16:895-901.
16. Kweon SS, Shin MH, Song HJ, Jeon DY, Choi JS. 2006. Seroprevalence and risk factors for hepatitis C virus infection among female commercial sex workers in South Korea who are not intravenous drug users. Am J Trop Med Hyg 74:1117-1121.
17. Lauer GM, Walker BD. 2001. Hepatitis C virus infection. N Engl J Med 345:41-52.
18. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BD. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191:1499-1512.
19. Lee WJ, Kang SM, Sung H, Won CH, Chang SE, Lee MW, Kim MN, Choi JH, Moon KC. 2010. Non-tuberculous mycobacterial infections of the skin: A retrospective study of 29 cases. J Dermatol 37:965-972.
20. Lehmann M, Meyer MF, Monazahian M, Tillmann HL, Manns MP, Wedemeyer H. 2004. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection. J Med Virol 73:387-391.
21. Maheshwari A, Ray S, Thuluvath PJ. 2008. Acute hepatitis C. Lancet 372:321-332.
22. Matthews-Greer JM, Caldito GC, Adley SD, Willis R, Mire AC, Jamison RM, McRae KL, King JW, Chang WL. 2001. Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus. Clin Diagn Lab Immunol 8:690-694.
23. Missiha S, Heathcote J, Arenovich T, Khan K, Canadian Pegasys Expanded Access Group. 2007a. Impact of Asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C. Am J Gastroenterol 102:2181-2188.
24. Missiha S, Heathcote J, Arenovich T, Khan K, Canadian Pegasys Expanded Access Group. 2007b. Impact of Asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C. Am J Gastroenterol 102:2181-2188.
25. Morand PDN, Minazzi H, Burnichon J, Pernollet M, Baud M, Zarski JP, Seigneurin JM. 2001. Lack of seroconversion in a health care worker after polymerase chain reaction-documented acute hepatitis C resulting from a needlestick injury. Clin Infect Dis 33:727-729.
26. Mosley JW, Operskalski EA, Tobler LH, Buskell ZJ, Andrews WW, Phelps B, Dockter J, Giachetti C, Seeff LB, Busch MP, Transfusion-transmitted Viruses Study and Retrovirus Epidemiology Donor Study Groups. 2008. The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy. J Viral Hepat 15:120-128.
27. Orland JR, Wright TL, Cooper S. 2001. Acute hepatitis C. Hepatology 33:321-327.
28. Pasquier C, Bujan L, Daudin M, Righi L, Berges L, Thauvin L, Berrebi A, Massip P, Puel J, Izopet J. 2003. Intermittent detection of hepatitis C virus (HCV) in semen from men with human immunodeficiency virus type 1 (HIV-1) and HCV. J Med Virol 69:344-349.
29. Pilli M, Zerbini A, Penna A, Orlandini A, Lukasiewicz E, Pawlotsky JM, Zeuzem S, Schalm SW, von Wagner M, Germanidis G, Lurie Y, Esteban JI, Haagmans BL, Hezode C, Lagging M, Negro F, Homburger Y, Neumann AU, Ferrari C, Missale G. 2007. HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project). Gastroenterology 133:1132-1143.
30. Santantonio T, Fasano M, Sinisi E, Guastadisegni A, Casalino C, Mazzola M, Francavilla R, Pastore G. 2005. Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance. J Hepatol 42:329-333.
31. Seeff LB. 1999. Natural history of hepatitis C. Am J Med 107:10S-15S.
32. Shata MT, Tricoche N, Perkus M, Tom D, Brotman B, McCormack P, Pfahler W, Lee DH, Tobler LH, Busch M, Prince AM. 2003. Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees. Virology 314:601-616.
33. Shepard CW, Finelli L, Alter MJ. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5:558-567.
34. Sherman KE, Shire NJ, Rouster SD, James Koziel M. Chung RT. Horn PS. 2005. Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients. Gastroenterology 128:313-327.
35. Shin HR. 2006. Epidemiology of hepatitis C virus in Korea. Intervirology 49:18-22.
36. Song JY, Sohn JW, Jeong HW, Cheong HJ, Kim WJ, Kim MJ. 2006. An outbreak of post-acupuncture cutaneous infection due to Mycobacterium abscessus. BMC Infect Dis 6:6.
37. Spada E, Mele A, Berton A, Ruggeri L, Ferrigno L, Garbuglia AR, Perrone MP, Girelli G, Del Porto P, Piccolella E, Mondelli MU, Amoroso P, Cortese R, Nicosia A, Vitelli A, Folgori A. 2004. Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance. Gut 53:1673-1681.
38. Sun CA, Chen HC, Lu CF, You SL, Mau YC, Ho MS, Lin SH, Chen CJ. 1999. Transmission of hepatitis C virus in Taiwan: Prevalence and risk factors based on a nationwide survey. J Med Virol 59:290-296.
39. Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A, Miller J, Manns M, Rehermann B. 2000. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 6:578-582.
40. Thomas DL, Seeff LB. 2005. Natural history of hepatitis C. Clin Liver Dis 9:383-398 vi.
41. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, Nelson KE, Strathdee SA, Johnson L, Laeyendecker O, Boitnott J, Wilson LE, Vlahov D. 2000. The natural history of hepatitis C virus infection: Host, viral, and environmental factors. JAMA 284:450-456.
42. Tillmann HL, Thompson AJ, Patel K, Wiese M, Tenckhoff H, Nischalke HD, Lokhnygina Y, Kullig U, Gobel U, Capka E, Wiegand J, Schiefke I, Guthoff W, Grungreiff K, Konig I, Spengler U, McCarthy J, Shianna KV, Goldstein DB, McHutchison JG, Timm J, Nattermann J. 2010. A polymorphism near IL28B is associated with spontaneous clearance, of acute hepatitis C virus and jaundice. Gastroenterology 139:1586-1592.
43. Torriani FJ, Ribeiro RM, Gilbert TL, Schrenk UM, Clauson M, Pacheco DM, Perelson AS. 2003. Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV coinfection. J Infect Dis 188:1498-1507.
44. Wasley A, Grytdal S, Gallagher K. 2008. Surveillance for acute viral hepatitis-United States, 2006. MMWR Surveill Summ 57:1-24.
45. Wiese M, Grungreiff K, Guthoff W, Lafrenz M, Oesen U, Porst H. 2005. Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany-A 25-year multicenter study. J Hepatol 43:590-598.